PeptidePedia The community reference

Multi-dose vial (revision 1)

Old revision·09:00, 28 Jan 2025·SharpsSukhi

This is an old revision of this page, as it stood at 09:00, 28 Jan 2025, saved by SharpsSukhi with the summary start article. It may differ substantially from the current revision, and any error it contains may since have been corrected.
Multi-dose vial
Compendial termMultiple-dose container
Defining featureIntended for more than one withdrawal
RequirementAntimicrobial preservative, with effectiveness demonstrated
Default period after initial puncture28 days, unless otherwise specified
Topic infobox · conventions

A multi-dose vial, termed a multiple-dose container in compendial language, is a container of an injectable preparation intended to permit withdrawal of successive portions of its contents without change in the strength, quality or purity of the remainder. The definition is functional: it describes an intention and the conditions that make the intention safe, not a size or a shape. A 10 mL vial may be a single-dose or a multiple-dose container depending on its formulation and its labelling.[1]

Two requirements follow from repeated entry. Because each penetration of the closure is an opportunity for microbial ingress, and because the contents are held at or near room temperature for a period afterwards, a multiple-dose preparation must contain an antimicrobial preservative whose effectiveness has been demonstrated by the challenge testing described in USP <51>. And because the preservative controls but does not eliminate risk, the period during which the container may be used after its first puncture is limited, conventionally to 28 days unless the manufacturer specifies otherwise.[2][3]

References

  1. ^ United States Pharmacopeia, General Chapter <659>, "Packaging and Storage Requirements", including definitions of single-dose and multiple-dose containers. USP–NF, current revision.
  2. ^ United States Pharmacopeia, General Chapter <51>, "Antimicrobial Effectiveness Testing". USP–NF, current revision.
  3. ^ United States Pharmacopeia, General Chapter <797>, "Pharmaceutical Compounding — Sterile Preparations", 2023 revision.